Status:
RECRUITING
Development of a Research Infrastructure for Understanding and Addressing Multiple Myeloma Disparities
Lead Sponsor:
University of California, Davis
Collaborating Sponsors:
Cancer Registry of Greater California
Conditions:
Multiple Myeloma
Eligibility:
All Genders
21+ years
Brief Summary
The objectives of the proposed study are to develop and evaluate protocols for ethnic/racial minority-specific research using cancer registry data. In conjunction with the Cancer Registry of Greater C...
Detailed Description
Eligible patients will include AAs, Latinos and AANHPIs who were diagnosed with a first primary, pathologically confirmed MM within the previous five years and who were at least 21 years of age at the...
Eligibility Criteria
Inclusion
- Diagnosed with a first primary pathologically confirmed case of Multiple Myeloma within the previous 5 years
- At least 21 years of age at the time of diagnosis
- Must have been diagnosed in one of the 48 counties in California
- Participant must be alive
- Identify as one of the following: African American, Latino, Asian American/Native Hawaiian/Pacific Islander, Non-Hispanic White
Exclusion
- People who have not been diagnosed with Multiple Myeloma
- Under the age of 21
- Pregnant
- Prisoner
Key Trial Info
Start Date :
September 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 30 2026
Estimated Enrollment :
4000 Patients enrolled
Trial Details
Trial ID
NCT04314752
Start Date
September 1 2020
End Date
May 30 2026
Last Update
September 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California Davis Comprehensive Cancer Center
Sacramento, California, United States, 95817